Tenax Therapeutics, Inc. · NASDAQ:TENX
Janus Henderson Group PLC reported a 9.90% stake in Tenax Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 14, 2025
Janus Henderson Group PLC reported a 9.90% stake in Tenax Therapeutics, Inc., 396,642 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 396,642
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 9.90% | 396,642 |
| Janus Henderson Biotech Innovation Master Fund Ltd | 9.90% | 396,642 |
Source
Related
- Tenax Therapeutics, Inc.
- Janus Henderson Group PLC
- Tenax Therapeutics, Inc. shareholders
- Schedule 13G · Janus Henderson Group PLC · Dec 8, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Feb 14, 2025
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026